availability of tirzepatide us https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a Compounded TIRZEPATIDE 5MG - Lyophilized

There have been subsequently a couple database studies that have come out, also with larger numbers of patients with breast cancer on GLP-1s, and it does seem like there is a signal towards improved overall survival

By activating GLP-1 receptors, semaglutide can help: Reduce appetite and cravings Quiet food noise Increase feelings of fullness Slow gastric emptying Support blood sugar balance Clinical trials have shown that semaglutide can lead to significant weight loss (up to 15% of body weight)* when paired with consistent lifestyle support

Resistance training is particularly important during weight loss to help preserve metabolic rate and functional capacity

Safety and Dosing : Tirzepatide affects blood sugar and digestion, so the dose must be carefully adjusted for each person

There are a number of nutrients needed to support this phase, including vitamins B2, B3, B5, B6, B12, folate, glutathione, and flavonoids